Please select the questions you want to include.
Select all questions
	Part A
	1. Contact name
	2. E-mail
	Part B
	1. What are the steps during the creation process from the initial idea to the final decision and the start of the actual plant genome research programme?
	2. How long took the design process from the initial idea till the first call?
	3. Who had the initial idea to create a plant genome research programme?
	4. Has there been a predecessor programme in plant genome research or in another related field?
	5. Have there been any studies (e.g. benchmarking, surveys, observation reports) before the plant genome research programme had been implemented? What was the influence of these studies on the design of the plant genome research programme?
	6. Does the design and thematic content of the plant genome research programme in your country / institution take into account information on any other national or international programme?
	7. Are there fixed rules for a programme design and initiation procedure in your institution or is the handling of programme design and initiation rather flexible and not fixed by regulations and changing from case to case?
	8. Have there been any standing committees / bodies / boards that have influenced the design and initiation process of the present plant genome research programme in your institution / country?
	9. Are there presently any standing committees / bodies / boards that influence the (re-)design and further development of the ongoing plant genome research programme in your country / institution?
	10. Are the legal responsibilities for decisions on different budgetary / programmatic levels graded in your country / institution? Who has the responsibility on wghat level in the area of plant genome research funding?
	11. Who is the (highest) representative to sign the final implementation document that starts the plant genome research programme in your country / institution?
	12. Did different groups that had been involved during the design process of the plant genome research programme pursue special objectives?
	13. How strong was the (political ) influence of the different groups during the design process of the plant genome research programme?
	14. How would you classify the character of the design process?
	15. Who has actively taken part in the writing and editing of the text of the plant genome research programme?
	16. Have there been any negative influences during the design and initiation process of the plant genome research programme and who exerted these adverse or opposing influences at what stage of the process?
	17. When will the next update (eventually re-design) process of the plant genome research programme of your country / institution take place?
	18. Is it difficult or easy to implement a transnational call within the plant genome research programme of your country / institution within ERA-PG?
	19. What else would be required for the implementation process of a transnational call in the plant genome research programme of your country / institution within ERA-PG?
	20. How long would it take to allocate the budget for a transnational call in the plant genome research programme of your country / institution within ERA-PG? synchronous / joint / other
	21. Whom would you nominate for participation in new design of a plant genome research programme in your country / institution - especially if thinking of ERA-PG?
	22. Where do you expect barriers for the general cooperation within ERA-PG?
	23. Where do you expect barriers for joint calls that are intended within ERA-PG in the near future?
	24. Where do you expect putative obstacles thinking of the design and initiation processes for a joint plant genome research programme within ERA-PG?
	Part C
	1. What are the relevant steps during the evaluation process from the incoming applications to the final evaluation decision in the plantr genome research programme?
	2. Which authority / institution issues and publicises the rules of procedure for application and evaluation in the plant genome research programme? Who is allowed to modify these rules?
	3. Which authority /institution offers further guidance notes and information for application / evaluation as well as interpretation support?
	4. Who offers consultancy for applicants?
	5. Who is in charge of the execution of the application and evaluation procedure? Who is organising and managing the evaluation procedure?
	6. Are there different project types or activities and are they dealt with differently during the evaluation process?
	7. What is the language of the calls?
	8. What is the language of the proposals?
	9. What are the elements that need to be addressed in a draft proposal? Are there any formal limitations concerning the page numbers?
	10. What are the parts required for a full proposal? Are there any formal limitations concerning the page numbers?
	11. What proposal submission system is used?
	12. Is it intended to implement an electronic submission system in the future?
	13. Who is holding the information about all the applicants during an ongoing application / evaluation procedure?
	14. How many steps comprise the evaluation procedure?
	15. Does the evaluation procedure include hearings / presentations of the applicants? If so, under what circumstances?
	16. Is there a meta-evaluation of the evaluation procedure by an independent observer?
	17. How many evaluators are involved in the proposal evaluation in the plant genome research programme of your country / institution? What is the origin / background of the evaluators?
	18. How are evaluators selected?
	19. Which stakeholders are / are not represented among the evaluators?
	20. Is there a standing evaluation board / committee of evaluators?
	21. Are the names of the evaluators publicly known or are they anonymous to the applicants?
	22. What are the rules for a total or partial exclusion of evaluators?
	23. Is it possible for an applicant to request the exclusion of a particular evaluator from the evaluation of their proposal? If so, How and under which circumstances?
	24. Do evaluators receive any payments for their work? What are the conditions? How much do they receive?
	25. Are there any evaluation guidelines provided to the evaluators?
	26. What are the evaluatgion criteria applied in the plant genome research programme of your country / institution?
	27. Is there a quantification of the evaluation criteria - eg. a point scoring system?
	28. Are there any evaluation forms that are used by the evaluators?
	29. What is the numerical proportion of number of evaluators to number of proposals?
	30. Can the final result of the evaluation procedure be revised / overruled by any institution / person afterwards? If so, under what circumstances?
	31. How many proposals are submitted on average per year within the plant genome research programme of your country / institution?
	32. What is the average success rate of the applications?
	33. What is the average rate of over-subscription in terms of budget?
	34. How long are the time lags from a call until start of a project?
	35. Are calls permanently open for the submission of proposals or are there any cut off dates / deadlines for submission?
	36. Where do you expect putative obstacles for general cooperation and joint calls within ERA-PG that are caused by the plant genome research programme of your country / organisation thinking especially of application and evaluation processes?
	37. Is it easy or difficult to change the rules and procedures for application and evaluation?
	Addendum 1
	Addendum 2
	Addendum 3
	Part D
	1. What is the organisational structure of the plant genome research programme in your country / organisation?
	2. How was the decision made and who decided on which person / agency will manage / will be in charge of the programme?
	3. Which authority / institution issues the administrative rules and procedures of the plant genome research programme? Who is allowed to modify these administrative rules and procedures?
	4. Who evaluates and revises the plant genome research programme in your country / institution? How does this process work? Does the assessment of the programme follow specific rules of procedure?
	5. How frequent is the revision of thematic orientation and content of the actual plant genome research programme in your country / institution
	6. Is there a long term roadmap for future calls and budget in the plant genome research programme in your country / institution? Has this roadmap been published?
	7. How many calls for proposals are there per year?
	8. Are cut-off dates / deadlines arranged in a periodic manner?
	9. Who decides on the timing of the cut off dates / deadlines?
	10. What is the average duration of a project (in months)? What is the average total budget of a project (in Euro)?
	11. Who is negotiating the project proposal on the side of the funding agency after its acceptance through the evaluation process?
	12. Is a consortium agreement a prerequisite for funding of projects with multiple partners?
	13. Who is responsible for monitoring, revision and evaluation of ongoing projects? How does revision and evaluation procedure work? Does the revision follow specific rules of procedure?
	14. How frequent is monitoring, revision and evaluation of a project?
	15. Which institution holds all the data about the plant genome research projects within the plant genome research programme?
	16. What kind of data about the projects within the plant genome research programme is publicly available? Where is it available and where can it be requested?
	17. Who is allowed to request the above mentioned data sets? Can the data sets be provided for an online (www) joint database within ERA_PG?
	18. What are the rules for dissemination and valorisation for projects within the plant genome research programme?
	19. Which authority / institution issues the rules for dissemination and valorisation?
	20. What are the rules and procedures for claiming rights on intellectual property that has been generated within projects of the plant genome research programme?
	21. What are the rules and procedures for using intellectual property that has been generated within projects of the plant genome research programme?
	22. Who is in charge of public relations of the plant genome research programme and the respective projects?
	23. Where do you expect putative obstacles for general cooperation and joint calls within ERA-PG that are caused by the plant genome research programmme of your country / organisation thinking especially of administration and management processes?